🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To evaluate tolerability and safety of SAR408701 when...
Status
Completed
Location
Investigational Site Number : 3920002
Start Date
2017-10-17
Trial ID
NCT03324113
Treatments Being Tested
This study is a prospective, open-label, multi-cohort, exploratory phase II...
Status
Withdrawn
Location
Erasmus MC
Start Date
2024-02-16
Trial ID
NCT05703555
Treatments Being Tested
Primary Objective: * Safety run-in part: to assess the tolerability and to...
Status
Terminated
Location
KU Medical Center_Investigational Site Number :8400002
Start Date
2020-10-26
Trial ID
NCT04524689
Treatments Being Tested
Primary Objectives: * Study was designed with multiple primary endpoints a...
Status
Terminated
Location
Florida Cancer Specialists South Division- Site Number : 8400020
Start Date
2020-02-06
Trial ID
NCT04154956
Primary Objectives: Doublet Cohort Part 1 (safety run-in): To assess the...
Status
Terminated
Location
Henry Ford Hospital Site Number : 8400005
Start Date
2020-08-31
Trial ID
NCT04394624
Treatments Being Tested
This is a Phase1, single-arm study for treatment. This is a prospective mul...
Status
Terminated
Location
Mary Crowley Cancer Research Center Site Number : 8400002
Start Date
2022-10-03
Trial ID
NCT05429762
Treatments Being Tested
Primary Objectives: Part 1: to confirm the recommended tusamitamab ravtans...
Status
Terminated
Location
Investigational Site Number : 0560002
Start Date
2021-11-16
Trial ID
NCT05071053
Treatments Being Tested
Primary Objectives: * To determine the maximum tolerated dose (MTD) of SAR...
Status
Terminated
Location
Yale University School of Medicine Site Number : 840002
Start Date
2014-07-23
Trial ID
NCT02187848
Treatments Being Tested
This is an open label single group, Phase 2, 1-arm study for treatment to e...
Status
Terminated
Location
Roswell Park Cancer Institute Site Number : 8400004
Start Date
2022-06-01
Trial ID
NCT05245071
Treatments Being Tested
Primary Objective: * For Cohort A, Cohort B, and Cohort C Part 2: To asses...
Status
Terminated
Location
AdventHealth Orlando Site Number : 8400001
Start Date
2021-03-29
Trial ID
NCT04659603
Treatments Being Tested